The first decade of Genome Wide Association Studies (GWAS) has uncovered a wealth of disease-2 associated variants. Two important derivations will be the translation of this information into a multiscale 3 understanding of pathogenic variants, and leveraging existing data to increase the power of existing and 4 future studies through prioritization. We explore edge prediction on heterogeneous networks-graphs 5 with multiple node and edge types-for accomplishing both tasks. First we constructed a network 6 with 18 node types-genes, diseases, tissues, pathophysiologies, and 14 MSigDB (molecular signatures 7 database) collections-and 19 edge types from high-throughput publicly-available resources. From this 8 network composed of 40,343 nodes and 1,608,168 edges, we extracted features that describe the topology 9 between specific genes and diseases. Next, we trained a model from GWAS associations and predicted the 10 probability of association between each protein-coding gene and each of 29 well-studied complex diseases.
Introduction
. Heterogeneous network integrates diverse information domains. We constructed a heterogeneous network with 18 metanodes (denoted with labels) and 19 metaedges (denoted by color). For each metanode, nodes are laid out circularly. Incorporating type information adds structure to a network which would otherwise appear as an undecipherable agglomeration of 40,343 nodes and 1,608,168 edges. Prediction Threshold B A Figure 2 . Predicting associations withheld for testing. Performance was evaluated on 25% of gene-disease pairs withheld for testing. A) Testing and training ROC curves. At top prediction thresholds, associated gene-disease pairs are recalled at a much higher rate than unassociated pairs are incorrectly classified as positives. The testing area under the curve (AUROC) is slightly greater than the training AUROC, demonstrating the method's lack of overfitting. Performance greatly exceeds random denoted by gray line. B) The precision-recall curve showing performance in the context of the low prevalence of associated gene-disease pairs (0.13%). Nevertheless, at top prediction thresholds, a high percentage of pairs classified as positives are truly associated. Prediction thresholds, shown as points and colored by value, align with the observed precision at that threshold. 7 (4 features), pathways (2) , transcriptional signatures of perturbations (1) and protein interactions (1) . 140 Despite the parsimony of the lasso, performance was similar between models with training AUROCs of 141 0.83 (ridge) and 0.82 (lasso). However, since multiple features from a correlated group may be causal, 142 the lasso model risks oversimplifying. Ridge regression disperses an effect across a correlated group of 143 features, providing users greater flexibility when interpreting predictions. From the ridge model, we 144 predicted the probability that each protein-coding gene was associated with each analyzed disease and 145 built a webapp to display the predictions (http://het.io/disease-genes/browse). Degree-preserving network permutations highlight the importance of edge-147 specificity for top predictions and ten features 148 Using Markov chain randomized edge-swaps, we created 5 permuted networks. Since metaedge-specific 149 node degree is preserved, features extracted from the permuted network retain unspecific effects. These while general effects gleaned from node degree performed reasonably well when ranking the entire spec-160 trum of protein-coding genes for association. A commonly-overlooked finding is that the discriminatory 161 ability of gene networks largely relies on node-degree rather than the edge-specificity [10] . However, we 162 found that for top predictions-which are the only predictions considered by many applications-edge-163 specificity was critical.
164
Interestingly, predictions from the permuted-network model displayed a reduced dynamic range with 165 none exceeding 4%, while predictions from the unpermuted-network model exceeded 75% ( Figure S4D ).
166
Therefore, even though they achieve reasonable AUROC, the permuted-network predictions would have greatly outperformed any individual feature, highlighting the importance of an integrative approach.
183
Features whose metapaths originate with an association (GaD) metaedge measure pleiotropy (Ta- Table 2 ). Feature descriptions are provided in Table S1 . ble S1). The four pleiotropic features were among the top performing features that did not rely on 185 set-based gene categorization ( Figure 4 ). Of the four features, GaD (any disease) had the highest AU-
186
ROC despite its lack of disease-specificity, reflecting both the sparsity of disease-specific features and 187 the existence of genetic overlap between seemingly disparate diseases. GaDmPmD and GaDaGaD per-188 formed best for immunologic diseases and were affected by permutation, indicating that genetic overlap 189 was greatest between immunologic diseases. On the other hand, the performance of GaDlTlD did not 190 decrease after permutation indicating disease colocalization was not a primary driver of genetic overlap. 191 We also observed that the lasso regression model discarded the majority of features with a minimal Perturbations. As expected this feature performed best for diseases with an immune pathophysiology.
202
The one well-performing neoplastic disease ( Figure 4 ) was chronic lymphocytic leukemia, a hematologic 203 cancer with a strong immune component [11] . Additionally, the performance of both the Perturbation ability on their own, they are broadly applicable (i.e. less susceptible to knowledge bias) and provide 217 orthogonal information that could enhance the overall performance of a model.
218
Case study: prioritizing multiple sclerosis associations 219 The WTCCC2 multiple sclerosis (MS) GWAS tested 465,434 SNPs for 9,772 cases and 17,376 controls 220 and identified over 50 independently associated loci [12] . Since the GWAS Catalog excludes targeted 221 arrays (such as ImmunoChip), this study remains the largest MS GWAS in the Catalog. To evaluate our 222 method's ability to prioritize associations identified in a future study, we masked the WTCCC2 MS study 223 from the GWAS Catalog and created a pre-WTCCC2 network. The number of high-confidence primary 224 MS associations was thus reduced from 50 to 13, with the 37 novel genes identified by WTCCC2 available 225 to evaluate performance. On the pre-WTCCC2 network, we extracted features, fit a ridge model, and 226 predicted each gene's probability of association with MS. Amongst all 18,993 potentially novel genes, the 227 37 WTCCC2 genes were ranked highly (AUROC = 0.79, Figure 5 ). 
r ig h t a li g n e d le f t a li g n e d Figure 5 . Prioritizing multiple sclerosis associations identified by a masked GWAS. From a network with the WTCCC2 MS associations omitted, we predicted probabilities of association for all potentially novel genes. The 37 novel genes identified by the WTCCC2 GWAS were considered positives, and the resulting performance was plotted. The ROC (A) and precision-recall (B) curves show performance, with AUCs in line with the testing performance across all diseases ( Figure 2 ). A prediction threshold (black cross) that resulted in high performance was selected as the discovery threshold for further analysis. As the classification threshold decreases along the precision-recall curve, the advent of each true positive is denoted by its gene symbol.
Prioritizing statistical candidates with network-based predictions identifies 229 novel multiple sclerosis genes 230 Finally, we designed a framework for discovering and validating novel MS genes that incorporates our 231 network-based predictions. Meta2.5 is a meta-analysis of all MS GWAS prior to the WTCCC2 study [13] . 232 We calculated genewise p-values for Meta2.5 using VEGAS [14] and observed a large enrichment in nom-233 inally significant (p < 0.05) genes, suggesting multiple potential associations ( Figure S8 ). We combined 234 this set of experimental candidates with the top predictions from the pre-WTCCC2 network to discover 235 genes with both strong statistical and biological evidence of association. To ensure novelty, we excluded 236 genes from GWAS-established MS loci and the extended MHC region. We chose a threshold (Table S3 ) for 237 network-based predictions that performed well in prioritizing the genes identified by WTCCC2 ( Figure 5 ).
238
This strategy discovered four genes, three of which-JAK2, REL, RUNX3 -achieved Bonferroni 239 validation on VEGAS-converted WTCCC2 p-values ( Table 4 ). The probability of the observed validation 240 rate occurring under random prioritization is 0.01 (Table S3 ), demonstrating that incorporating our network-based predictions as a prior increased study power. JAK2 displays overexpression in MS-affected 242 Th17 cells [15] and was implicated in an interactome-based prioritization of GWAS [2] . RUNX3, a 243 transcription factor influencing T lymphocyte development, has been associated with celiac disease [16] 244 and ankylosing spondylitis [17] and was hypermethylated in systemic lupus erythematosus patients [18] . 245 The region containing REL was uncovered in a recent MS ImmunoChip-based study with 14,498 cases [19, 246 p. S40]. For the gene-dense region containing REL, the ImmunoChip study reported a long non-coding 247 RNA, LINC01185, overlapping the lead-SNP, rs842639. However, since greater than 80% of the genome 248 shows evidence of transcription [20] , the probability of incidental overlap with long non-coding RNA is 249 high. REL, however, is an essential transcription factor for lymphocyte development [21] and plays a 250 critical role in autoimmune inflammation [22] . Hence, gene prioritization through integrative analyses 251 offers not only to streamline loci discovery but also subsequent causal gene identification.
252

Discussion
253
In this work, we developed a framework to predict the probability that each protein-coding gene is asso- such as tissue-specificity [23] , protein interactions [24] , pathways [1] , or disease similarity [25] . The method 267 presented here integrates disparate data sources, learns their importance, and unifies them under a com-268 mon framework enabling comparison. Therefore, we can conclude that perturbation gene sets-the core of 269 our top-performing feature-are an underutilized resource for disease-associated gene prioritization. Not 270 only did perturbations encompass other set-based gene categorizations, but they greatly outperformed 271 features based on protein interactions, pathways, and tissue-specificity, which form the basis of several 272 prominent prioritization techniques. In addition to characterizing the overall importance of each feature, 273 our online prediction browser visually decomposes an individual prediction into its components. 274 We observed a prominent influence of pleiotropy, consistent with previous studies that identified perva-275 sive overlap of susceptibility loci across complex diseases [26] , especially those of autoimmune nature [27] . 276 Since many existing prioritization techniques are agnostic to the compendia of GWAS associations, they 277 fail to adequately leverage pleiotropy. Unlike approaches initiated from a user-provided gene list, our 278 study only provides predictions for 29 diseases. By not relying on user-provided input, our predictions 279 a graph consisting of node types connected by edge types. When referring to this graph of types, we use 317 the prefix 'meta'. Metagraphs-called schemas in previous work [6, 7] -consist of metanodes connected 318 by metaedges. In a heterogeneous network, each path, a series of edges with common intermediary nodes, 319 corresponds to a metapath representing the type of path. A path's metapath is the series of metaedges 320 corresponding to that path's edges. The possible metapaths within a heterogeneous network can be 321 enumerated by traversing the metagraph. We implemented this framework as an object-oriented data 322 structure in python and named the resulting package hetio. Users are free to browse, use, or contribute 323 to the software, through the online repository (http://github.com/dhimmel/hetio).
324
Network construction 325 Protein-coding genes were extracted from the HGNC database [31] . Resources were mapped to HGNC 326 terms via gene symbol (ambiguous symbols were resolved in the order: approved, previous, synonyms) 327 or Entrez identifiers. Disease nodes were taken from the Disease Ontology (DO) [32] . Due to the limited 328 number of diseases with GWAS, relevant disease references were manually mapped to the DO. Tissues 329 were taken from the BRENDA Tissue Ontology (BTO) [33] . Only tissues with profiled expression were Associations were ordered by confidence, sorting on following criteria: high/low confidence, p-value (low 353 to high), and recency. In order of confidence, associations were overlapped by their windows into diseasespecific loci. By organizing associations into loci, associations from multiple studies tagging the same 355 underlying signal were condensed. A locus was classified as high-confidence if any of its composite 356 associations were high-confidence and low-confidence otherwise.
357
For each disease-specific loci, we attempted to identify a primary gene. The primary gene was resolved 358 in the following order: 1) the mode author-reported gene; 2) the containing gene for an intragenic lead- Loci where ambiguity was unresolvable or where no genes were returned did not receive a primary gene.
363
All non-primary genes-genes that were author-reported, overlapping the lead-SNP, or immediately up 364 or downstream from the lead-SNP-were considered secondary.
365
Accordingly, four categories of processed associations were created: high-confidence primary, high-366 confidence secondary, low-confidence primary, and low-confidence secondary. We assume that our pri-367 mary gene annotation for each loci represents the single causal gene responsible for the association. To 368 investigate the validity of this assumption, we evaluated the performance of our predictions separately 369 using each category of association as positives ( Figure S7 ). For both confidence levels, primary associa-370 tions outperformed secondary associations suggesting our method succeeded at categorizing causal genes 371 as primary. However, for high-confidence secondary associations, the AUROC equaled 0.74, which could 372 result from multiple causal genes per loci or categorizing sole causal genes as secondary. The perfor-373 mance decline from high to low confidence associations was severe, pointing to a preponderance of falsely 374 identified loci in the GWAS Catalog when p > 5 × 10 −8 or sample size drops below 1000.
375
Protein interactions 376
Physical protein-protein interactions were extracted from iRefIndex 12.0, a compilation of 15 primary 377 interaction databases [36] . The iRefIndex was processed with ppiTrim to convert proteins to genes, 378 remove protein complexes, and condense duplicated entries [37] . 379 
Tissue-specific gene expression 380
Tissue-specific gene expression levels were extracted from the GNF Gene Expression Atlas [38] . Starting Disease localization was calculated for the 77 tissues with expression profiles. Literature co-occurrence 387 was used to assess whether a tissue is affected by a disease. We used CoPub 5.0 to extract R-scaled 388 scores between tissues and diseases measuring whether two terms occurred together in Medline abstracts more than would be expected by chance [39] . DO terms for diseases with GWAS and BTO tissues with 390 expression profiles were manually mapped to the 'biological identifier' terminology used by CoPub. The 391 R-scaled score was used as the threshold criteria for TlD edge inclusion.
392
Feature computation metrics 393 The simplest metapath-based metric is path count (PC ): the number of paths, of a specified metapath, 394 between a source and target node. However, PC does not adjust for the extent of graph connectivity 395 along the path. Paths traversing high-degree nodes will account for a large portion of the PC, despite 396 high-degree nodes frequently representing a biologically broad or vague entity with little informativeness.
397
The previous work evaluated several metrics that include a PC denominator to adjust for connectivity and 398 reported that normalized path count (NPC ) performed best [7] . The denominator for NPC equals the 399 number of paths from the source to any target plus the number of paths from any target to the source. We 400 adopt the any source/target concept to compute the two GaD features. However, dividing the PC by a 401 denominator is flawed because each path composing the PC deserves a distinct degree adjustment. If two 402 paths-one traversing only high-degree nodes and one traversing only low-degree nodes-compose the PC, 403 the network surrounding the high-degree path will monopolize the NPC denominator and overwhelm the 404 contribution of the low-degree path despite its specificity. Therefore, we developed the degree-weighted Regularized logistic regression requires a parameter, λ, setting the strength of regularization. We op-413 timized λ separately for each model fit. Using 10-fold cross-validation and the "one-standard-error" 414 rule to choose the optimal λ from deviance, we adopted a conservative approach designed to prevent 415 overfitting [40] . 416 On the training set of gene-disease pairs, we optimized the elastic net mixing parameter (α), the 417 DWPC damping exponent (w ), and two edge inclusion thresholds. First, we optimized α and w on the 418 20 features whose metapaths did not include threshold-dependent metaedges. For each combination of α 419 and w, we calculated average testing AUROC using 20-fold cross-validation repeated for 10 randomized 420 partitionings. After setting α and w ( Figure S3A ), we jointly optimized the two edge-inclusion thresholds 421 using the AUROC for the GeTlD feature, whose metapath is composed from the two edges requiring 422 thresholds ( Figure S3B ). Figure S1 . Bipartite network of gene-disease associations. Gene-disease associations were extracted from the GWAS Catalog. Here we show the 698 high-confidence primary associations for the 29 diseases with at least 10 associations. Diseases (large nodes) and their incident edges are colored according to disease pathophysiology. The network highlights pervasive pleiotropy as well as the overlap of susceptibility genes among autoimmune diseases. Figure S2 . Heterogeneous network edge prediction methodology. A) We constructed the network according to a schema, called a metagraph, which is composed of metanodes (node types) and metaedges (edge types). B) The network topology connecting a gene and disease node is measured along metapaths (types of paths). Starting on Gene and ending on Disease, all metapaths length three or less are computed by traversing the metagraph. C) A hypothetical graph subset showing select nodes and edges surrounding IRF1 and multiple sclerosis. To characterize this relationship, features are computed that measure the prevalence of a specific metapath between IRF1 and multiple sclerosis. D) Two features (for the GeTlD and GiGaD metapaths) are calculated to describe the relationship between IRF1 and multiple sclerosis. The metric underlying the features is degree-weighted path count (DWPC ). First, for the specified metapath, all paths are extracted from the network. Next, each path receives a path-degree product measuring its specificity (calculated from node-degrees along the path, D path ). This step requires a damping exponent (here w = 0.5), which adjusts how severely high-degree paths are downweighted. Finally, the path-degree products are summed to produce the DWPC. Figure S3 . Parameter optimization. Using the training network, optimal parameter values (yellow dashed lines) were chosen. A) Using average cross-validated AUROC to assess performance, six elastic net mixing parameters were evaluated. For each mixing parameter value α, 10 feature metrics were evaluated: the DWPC for 9 weighting exponents (w, magenta with a 99.99% loess confidence band) and the NPC (violet with a 99.99% confidence interval). The DWPC with w = 0.4 outperformed the NPC, the best metric from previous work, as well as the path count which equals the DWPC when w = 0. Performance variability was minimized when α = 0. B) Edge-inclusion thresholds for two metaedges were jointly optimized. Expression threshold refers to the minimum microarray intensity required for a tissue-specific expression (GeT ) edge. Localization threshold refers to the minimum literature co-occurrence score required for a disease localization (TlD) edge. Treating the DWPC (w = 0.4) for the GeTlD metapath as a classifier, the AUROC was calculated at each pairwise threshold combination. The optimal thresholds were chosen as the center of a stable, high-performing, and computationally-feasible section of the solution space. Figure S5 . Disease, feature, and model-specific performance across permuted-network models. Disease, feature, and model-specific AUROCs were calculated separately for each of 5 permuted networks and averaged. The figure is analogous to Figure 4 , except all measures refer to permuted-network performance. Disease-specific performance tends towards the mean, as disease-specific information has been altered by permutation. For features ending with an association (GaD) metaedge, global performance exceeds disease-specific performance. metabolic  17  11  1  0  asthma  immunologic  17  23  13  4  psoriasis  immunologic  16  14  5  5  schizophrenia  psychiatric  15  27  20  13  chronic lymphocytic leukemia  neoplastic  14  16  3  4  migraine  unspecific  13  15  38  58  Alzheimer's disease  degenerative  12  11  27  18  Graves' disease  immunologic  12  15  1  1  Parkinson's disease  degenerative  12  21  8  13  atopic dermatitis  immunologic  11  15  5  1  bipolar disorder  psychiatric  11  34  26  74  lung carcinoma  neoplastic  10  14  6  6  ankylosing spondylitis  immunologic  10  5  6  6   Table 3 . Diseases. Associations were predicted for 29 diseases with at least 10 positives. For these diseases, the number of high-confidence primary (HC-P), high-confidence secondary (HC-S), low-confidence primary (LC-P), and low-confidence secondary associations (LC-S) that were extracted from the GWAS Catalog is indicated. 
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